Catalyst OrthoScience raises $12.7M for new total shoulder system — 3 insights

Written by Alan Condon | May 14, 2019 | Print  |

Naples, Fla.-based medical device company Catalyst OrthoScience has raised $12.7 million in an oversubscribed financing round led by Cincinnati-based growth equity firm River Cities Capital Funds.

Three insights:

1. Catalyst's CSR Total Shoulder System represents a new surgical technique that creates a multiplanar chamfer cut on the humeral head, minimizing bone removal and preserving the strongest bone for the humeral component fixation.

2. The angled glenoid tools assist in the glenoid exposure and reduce retraction on the soft tissue. The Catalyst CSR system has been used in over 1,000 surgeries.

3. Catalyst chairman and CEO Brian K. Hutchinson said the funding will help fuel the company's growth "through increased inventory, expanded distribution and new product development" as well as hiring "additional talent."

More articles on devices:
Xenco Medical launches 1st interactive vending machine for spine surgery instruments — 4 insights
FDA approves ChoiceSpine for two new cervical spinal fusion devices — 3 insights
FDA approves new spina bifida treatment that utilizes scopes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers